Merck and Calla Lily Partner to Advance Callavid Platform

Merck and Calla Lily partner to advance Callavid platform

Merck and Calla Lily Clinical Care have announced a strategic partnership to advance Callavid, an intravaginal drug delivery platform.The post Merck and Calla Lily partner to advance Callavid platform appeared first on Hospital Management.

Calla Lily Clinical Care and Merck announce collab to advance drug delivery platform

Calla Lily Clinical Care, a women’s health-focused medtech company, and Merck, a science and technology company, have entered a strategic collaboration to support the continued development of Callavid, a platform for intravaginal drug delivery.

Calla Lily Clinical Care and Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform

Enhancing patient treatment experience and care with a new self-administered solution for vaginal therapeutics Versatile platform technology developed from a safe, award-winning, FDA-cleared medical device Strategic collaboration supporting the continued development of a novel intravaginal drug delivery approach to address unmet needs in women’s health LONDON--(BUSINESS WIRE)--Calla Lily Clinical Care, a women’s health-focused medical technology…